|
1
|
Chang ET and Adami HO: The enigmatic
epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol
Biomarkers Prev. 15:1765–1777. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang JB, Jiang Y, Liang H, Li P, Xiao HJ,
Ji J, Xiang W, Shi JF, Fan YG, Li L, et al: Attributable causes of
cancer in China. Ann Oncol. 23:2983–2989. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jia WH, Huang QH, Liao J, Ye W, Shugart
YY, Liu Q, Chen LZ, Li YH, Lin X, Wen FL, et al: Trends in
incidence and mortality of nasopharyngeal carcinoma over a 20-25
year period (1978/1983-2002) in Sihui and Cangwu counties in
southern China. BMC Cancer. 6:1782006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yi JL, Gao L, Huang XD, Li SY, Luo JW, Cai
WM, Xiao JP and Xu GZ: Nasopharyngeal carcinoma treated by radical
radiotherapy alone: Ten-year experience of a single institution.
Int J Radiat Oncol Biol Phys. 65:161–168. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ong YK, Heng DM, Chung B, Leong SS, Wee J,
Fong KW, Tan T and Tan EH: Design of a prognostic index score for
metastatic nasopharyngeal carcinoma. Eur J Cancer. 39:1535–1541.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lai SZ, Li WF, Chen L, Luo W, Chen YY, Liu
LZ, Sun Y, Lin AH, Liu MZ and Ma J: How does intensity-modulated
radiotherapy versus conventional two-dimensional radiotherapy
influence the treatment results in nasopharyngeal carcinoma
patients? Int J Radiat Oncol Biol Phys. 80:661–668. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee AW, Sze WM, Au JS, Leung SF, Leung TW,
Chua DT, Zee BC, Law SC, Teo PM, Tung SY, et al: Treatment results
for nasopharyngeal carcinoma in the modern era: The Hong Kong
experience. Int J Radiat Oncol Biol Phys. 61:1107–1116. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hui EP, Leung SF, Au JS, Zee B, Tung S,
Chua D, Sze WM, Law CK, Leung TW and Chan AT: Lung metastasis alone
in nasopharyngeal carcinoma: A relatively favorable prognostic
group. A study by the Hong Kong Nasopharyngeal Carcinoma Study
Group. Cancer. 101:300–306. 2004.
|
|
10
|
Yarden Y, Kuang WJ, Yang-Feng T, Coussens
L, Munemitsu S, Dull TJ, Chen E, Schlessinger J, Francke U and
Ullrich A: Human proto-oncogene c-kit: A new cell surface receptor
tyrosine kinase for an unidentified ligand. EMBO J. 6:3341–3351.
1987.PubMed/NCBI
|
|
11
|
Dagher R, Cohen M, Williams G, Rothmann M,
Gobburu J, Robbie G, Rahman A, Chen G, Staten A, Griebel D, et al:
Approval summary: Imatinib mesylate in the treatment of metastatic
and/or unresectable malignant gastrointestinal stromal tumors. Clin
Cancer Res. 8:3034–3038. 2002.PubMed/NCBI
|
|
12
|
Sobin LH, Gospodarowicz MK and Wittekind
C: TNM classification of malignant tumours. 7th. Wiley Blackwell;
Chichester: 2010
|
|
13
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A III: American Joint Committee on Cancer
(AJCC)Cancer staging manual. 7th. Springer; New York: 2010
|
|
14
|
Bar-Sela G, Kuten A, Ben-Eliezer S,
Gov-Ari E and Ben-Izhak O: Expression of HER2 and C-KIT in
nasopharyngeal carcinoma: Implications for a new therapeutic
approach. Mod Pathol. 16:1035–1040. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bar-Sela G, Ben Arush MW, Sabo E, Kuten A,
Minkov I and Ben-Izhak O: Pediatric nasopharyngeal carcinoma:
Better prognosis and increased c-Kit expression as compared to
adults. Pediatr Blood Cancer. 45:291–297. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sheu LF, Lee WC, Lee HS, Kao WY and Chen
A: Co-expression of c-kit and stem cell factor in primary and
metastatic nasopharyngeal carcinomas and nasopharyngeal epithelium.
J Pathol. 207:216–223. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Charfi S, Khabir A, Ayadi L, Mseddi M,
Makni H, Gorbel A, Daoud J, Frikha M, Jlidi R, Busson P, et al:
Expression of c-kit in North African nasopharyngeal carcinomas:
Correlation with age and LMP1. Cancer Radiother. 11:247–251.
2007.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rohr UP, Rehfeld N, Pflugfelder L, Geddert
H, Müller W, Steidl U, Fenk R, Gräf T, Schott M, Thiele KP, et al:
Expression of the tyrosine kinase c-kit is an independent
prognostic factor in patients with small cell lung cancer. Int J
Cancer. 111:259–263. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang PY, Hong MH, Zhang X, Mai HQ, Luo DH
and Zhang L: C-KIT overexpression and mutation in nasopharyngeal
carcinoma cell lines and reactivity of Imatinib on these cell
lines. Chin J Cancer. 29:131–135. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hui EP, Lui VW, Wong CS, Ma BB, Lau CP,
Cheung CS, Ho K, Cheng SH, Ng MH and Chan AT: Preclinical
evaluation of sunitinib as single agent or in combination with
chemotherapy in nasopharyngeal carcinoma. Invest New Drugs.
29:1123–1131. 2011. View Article : Google Scholar : PubMed/NCBI
|
